What did Exact Sciences Corporation pay for Genomic Health, Inc.?

Exact Sciences Corporation acquired Genomic Health, Inc. for $2.38B in 2019 (32.2x EBITDA), equivalent to 5.30x revenue. Target revenue was approximately $452.0M. Target EBITDA was approximately $74.0M.

What does Genomic Health, Inc. do?

Genomic Health, Inc. is a laboratory services business.

What multiple did Exact Sciences Corporation pay for Genomic Health, Inc.?

32.2x EBITDA and 5.30x revenue, based on disclosed deal value of $2.38B and disclosed financials.

M&A TRANSACTION · 2019

Genomic Health, Inc. acquired by Exact Sciences Corporation

$2.38B· 32.2x EBITDA· 5.30x revenue

Target

Genomic Health, Inc.

Acquirer

Exact Sciences Corporation

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$452.0M

EBITDA

$74.0M

Deal Value

$2.38B

EV/EBITDA

32.2x

Context

This $2.38B acquisition of Genomic Health, Inc. by Exact Sciences Corporation sits in the laboratory services sub-vertical. The 32.2x EBITDA multiple paid in 2019 can be compared against the population median for laboratory services transactions of similar size on our Laboratory Services valuation hub. Exact Sciences Corporation is acquiring as a strategic buyer; see how strategic acquirers typically price laboratory services businesses on our Laboratory Services strategic buyer-pool page.

Source

Data sourced from SEC Fairness Opinion — primary source. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own laboratory services

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the Genomic Health, Inc. acquisition.

Citation: ExitValue.ai. (2019). Genomic Health, Inc. acquired by Exact Sciences Corporation. https://exitvalue.ai/deals/genomic-health-inc-acquired-by-exact-sciences-corporation-fairness-opi